Hodges Capital Management Inc. Novavax Inc Transaction History

Hodges Capital Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$6.81 - $9.74 $68,100 - $97,400	10,000 New	10,000 $72,000
Q4 2021 Feb 07, 2022	SELL	$134.56 - $217.97 $336,400 - $544,925	-2,500 Closed	0 $0
Q3 2021 Oct 06, 2021	BUY	$177.8 - $270.58 $88,900 - $135,290	500 Added 25.0%	2,500 $518,000
Q3 2020 Oct 15, 2020	SELL	$79.44 - $178.51 $79,440 - $178,510	-1,000 Reduced 33.33%	2,000 $217,000
Q2 2020 Jul 22, 2020	BUY	$13.86 - $83.61 $41,580 - $250,830	3,000 New	3,000 $250,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $629M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Hodges Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hodges Capital Management Inc. with notifications on news.